NM_021971.4(GMPPB):c.551= (p.Gln184=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000527815] |
Chr3:49722606 [GRCh38] Chr3:49760039 [GRCh37] Chr3:3p21.31 |
benign |
NM_021971.4(GMPPB):c.130-6T>G |
single nucleotide variant |
not provided [RCV000550123] |
Chr3:49723478 [GRCh38] Chr3:49760911 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.331G>A (p.Val111Met) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000550887] |
Chr3:49723043 [GRCh38] Chr3:49760476 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.392G>C (p.Gly131Ala) |
single nucleotide variant |
not provided [RCV000520596] |
Chr3:49722982 [GRCh38] Chr3:49760415 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.456_457CA[1] (p.Thr153fs) |
microsatellite |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000551670] |
Chr3:49722698..49722699 [GRCh38] Chr3:49760131..49760132 [GRCh37] Chr3:3p21.31 |
pathogenic |
GRCh38/hg38 3p21.31-14.3(chr3:49461000-55314500)x1 |
copy number loss |
See cases [RCV000051511] |
Chr3:49461000..55314500 [GRCh38] Chr3:49498433..55348528 [GRCh37] Chr3:49473437..55323568 [NCBI36] Chr3:3p21.31-14.3 |
pathogenic |
NM_021971.2(GMPPB):c.1000G>A |
single nucleotide variant |
Congenital myasthenic syndrome [RCV000788090]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000054432]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651273]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000054433] |
Chr3:49721835 [GRCh38] Chr3:49759268 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic |
NM_021971.4(GMPPB):c.220C>T (p.Arg74Ter) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000054434] |
Chr3:49723293 [GRCh38] Chr3:49760726 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.64C>T (p.Pro22Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000054435] |
Chr3:49723663 [GRCh38] Chr3:49761096 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.553C>T (p.Arg185Cys) |
single nucleotide variant |
Inborn genetic diseases [RCV000623944]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000200261]|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14 [RCV000054436]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000054437]|Muscular dystrophy-dystroglycanopathy [RCV000503216] |
Chr3:49722604 [GRCh38] Chr3:49760037 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic |
NM_021971.4(GMPPB):c.95C>T (p.Pro32Leu) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000684892]|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14 [RCV000054438]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000209926]|not provided [RCV000493576] |
Chr3:49723632 [GRCh38] Chr3:49761065 [GRCh37] Chr3:3p21.31 |
pathogenic|uncertain significance |
NM_021971.4(GMPPB):c.860G>A (p.Arg287Gln) |
single nucleotide variant |
Inborn genetic diseases [RCV001266808]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000553832]|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14 [RCV000054439]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000209893]|not provided [RCV000520160] |
Chr3:49722056 [GRCh38] Chr3:49759489 [GRCh37] Chr3:3p21.31 |
pathogenic|uncertain significance |
NM_021971.4(GMPPB):c.79G>C (p.Asp27His) |
single nucleotide variant |
Muscular dystrophy [RCV000610921]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000533184]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000054440]|not provided [RCV000444697] |
Chr3:49723648 [GRCh38] Chr3:49761081 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic |
NM_021971.4(GMPPB):c.988G>A (p.Val330Ile) |
single nucleotide variant |
Inborn genetic diseases [RCV000623470]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651278]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000054441]|Muscular dystrophy-dystroglycanopathy [RCV000501778]|not provided [RCV000440664] |
Chr3:49721847 [GRCh38] Chr3:49759280 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic|uncertain significance |
GRCh38/hg38 3p21.31-21.2(chr3:45879883-50749922)x4 |
copy number gain |
See cases [RCV000133650] |
Chr3:45879883..50749922 [GRCh38] Chr3:45921375..50787353 [GRCh37] Chr3:45896379..50762357 [NCBI36] Chr3:3p21.31-21.2 |
pathogenic |
GRCh37/hg19 3p21.31(chr3:49758015-49829191)x3 |
copy number gain |
Ductal breast carcinoma [RCV000207221] |
Chr3:49758015..49829191 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.308C>T (p.Pro103Leu) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000211125] |
Chr3:49723066 [GRCh38] Chr3:49760499 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.760G>A (p.Val254Met) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000211128]|not provided [RCV000430158] |
Chr3:49722239 [GRCh38] Chr3:49759672 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic |
NM_021971.4(GMPPB):c.859C>T (p.Arg287Trp) |
single nucleotide variant |
Muscular dystrophy [RCV000609930]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000698947]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000211126] |
Chr3:49722057 [GRCh38] Chr3:49759490 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic |
GRCh37/hg19 3p22.2-21.31(chr3:37028313-49929220)x3 |
copy number gain |
See cases [RCV000240519] |
Chr3:37028313..49929220 [GRCh37] Chr3:3p22.2-21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.640+11G>A |
single nucleotide variant |
not specified [RCV000246880] |
Chr3:49722421 [GRCh38] Chr3:49759854 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.728G>A (p.Arg243Gln) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001226319]|not specified [RCV000251834] |
Chr3:49722271 [GRCh38] Chr3:49759704 [GRCh37] Chr3:3p21.31 |
likely benign|uncertain significance |
NM_021971.4(GMPPB):c.376C>G (p.His126Asp) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000539042]|not specified [RCV000242290] |
Chr3:49722998 [GRCh38] Chr3:49760431 [GRCh37] Chr3:3p21.31 |
benign |
NM_021971.4(GMPPB):c.330C>T (p.Asp110=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000533737]|not specified [RCV000252042] |
Chr3:49723044 [GRCh38] Chr3:49760477 [GRCh37] Chr3:3p21.31 |
benign |
NM_021971.4(GMPPB):c.260-1G>A |
single nucleotide variant |
not provided [RCV000256064] |
Chr3:49723115 [GRCh38] Chr3:49760548 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.204G>A (p.Glu68=) |
single nucleotide variant |
not specified [RCV000242508] |
Chr3:49723398 [GRCh38] Chr3:49760831 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.211-15del |
deletion |
not specified [RCV000247292] |
Chr3:49723317 [GRCh38] Chr3:49760750 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.607_609del (p.Lys203del) |
deletion |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000552493] |
Chr3:49722463..49722465 [GRCh38] Chr3:49759896..49759898 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1048G>A (p.Gly350Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001081525]|not provided [RCV000726214]|not specified [RCV000391570] |
Chr3:49721787 [GRCh38] Chr3:49759220 [GRCh37] Chr3:3p21.31 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_021971.4(GMPPB):c.931C>T (p.Arg311Cys) |
single nucleotide variant |
Inborn genetic diseases [RCV000624021]|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000529420]|not provided [RCV000522572] |
Chr3:49721985 [GRCh38] Chr3:49759418 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.554G>A (p.Arg185His) |
single nucleotide variant |
not provided [RCV000730511] |
Chr3:49722603 [GRCh38] Chr3:49760036 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.225C>T (p.Ile75=) |
single nucleotide variant |
not specified [RCV000604622] |
Chr3:49723288 [GRCh38] Chr3:49760721 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.640+1G>C |
single nucleotide variant |
not provided [RCV000523645] |
Chr3:49722431 [GRCh38] Chr3:49759864 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.1077C>G (p.Ile359Met) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000537490] |
Chr3:49721758 [GRCh38] Chr3:49759191 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.365_366dup (p.Phe123fs) |
duplication |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000527021] |
Chr3:49723007..49723008 [GRCh38] Chr3:49760440..49760441 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.562-9C>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000540404]|not specified [RCV000610990] |
Chr3:49722519 [GRCh38] Chr3:49759952 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.952-14A>G |
single nucleotide variant |
not specified [RCV000413124] |
Chr3:49721897 [GRCh38] Chr3:49759330 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.529A>G (p.Ile177Val) |
single nucleotide variant |
Global developmental delay [RCV000449525] |
Chr3:49722628 [GRCh38] Chr3:49760061 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.403-6A>G |
single nucleotide variant |
not specified [RCV000445035] |
Chr3:49722760 [GRCh38] Chr3:49760193 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.309T>C (p.Pro103=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000557516]|not specified [RCV000438003] |
Chr3:49723065 [GRCh38] Chr3:49760498 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.403-16C>T |
single nucleotide variant |
not specified [RCV000441928] |
Chr3:49722770 [GRCh38] Chr3:49760203 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.-29G>C |
single nucleotide variant |
not specified [RCV000425281] |
Chr3:49723755 [GRCh38] Chr3:49761188 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.1017C>T (p.Asn339=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651281]|not specified [RCV000436069] |
Chr3:49721818 [GRCh38] Chr3:49759251 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.702G>A (p.Gln234=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000875949]|not specified [RCV000433903] |
Chr3:49722297 [GRCh38] Chr3:49759730 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.951+9G>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000546590]|not provided [RCV001200164]|not specified [RCV000427085] |
Chr3:49721956 [GRCh38] Chr3:49759389 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.1041_1043dup (p.Ser348dup) |
duplication |
not provided [RCV000483980] |
Chr3:49721791..49721792 [GRCh38] Chr3:49759224..49759225 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.787G>A (p.Gly263Ser) |
single nucleotide variant |
not provided [RCV000480038] |
Chr3:49722129 [GRCh38] Chr3:49759562 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1018G>A (p.Gly340Arg) |
single nucleotide variant |
not provided [RCV000478147] |
Chr3:49721817 [GRCh38] Chr3:49759250 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.210G>A (p.Arg70=) |
single nucleotide variant |
not provided [RCV000497846] |
Chr3:49723392 [GRCh38] Chr3:49760825 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.967G>A (p.Val323Met) |
single nucleotide variant |
not provided [RCV000492872] |
Chr3:49721868 [GRCh38] Chr3:49759301 [GRCh37] Chr3:3p21.31 |
uncertain significance |
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3 |
copy number gain |
See cases [RCV000511055] |
Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29 |
pathogenic |
NM_021971.4(GMPPB):c.831C>T (p.Gly277=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000541214] |
Chr3:49722085 [GRCh38] Chr3:49759518 [GRCh37] Chr3:3p21.31 |
uncertain significance |
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986) |
copy number gain |
See cases [RCV000512358] |
Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29 |
pathogenic |
NM_021971.4(GMPPB):c.453T>C (p.Ala151=) |
single nucleotide variant |
not specified [RCV000609542] |
Chr3:49722704 [GRCh38] Chr3:49760137 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.561+15G>A |
single nucleotide variant |
not specified [RCV000608318] |
Chr3:49722581 [GRCh38] Chr3:49760014 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.477C>T (p.Phe159=) |
single nucleotide variant |
not specified [RCV000611870] |
Chr3:49722680 [GRCh38] Chr3:49760113 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.210+9_210+10del |
microsatellite |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651280] |
Chr3:49723382..49723383 [GRCh38] Chr3:49760815..49760816 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.459A>G (p.Thr153=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651279] |
Chr3:49722698 [GRCh38] Chr3:49760131 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.956G>A (p.Arg319His) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651277] |
Chr3:49721879 [GRCh38] Chr3:49759312 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.374G>A (p.Arg125Gln) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651276] |
Chr3:49723000 [GRCh38] Chr3:49760433 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.878G>A (p.Arg293Gln) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651275] |
Chr3:49722038 [GRCh38] Chr3:49759471 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.218T>C (p.Ile73Thr) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651274] |
Chr3:49723295 [GRCh38] Chr3:49760728 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.877C>T (p.Arg293Trp) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651272] |
Chr3:49722039 [GRCh38] Chr3:49759472 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1009T>C (p.Tyr337His) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000651271] |
Chr3:49721826 [GRCh38] Chr3:49759259 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.688T>C (p.Cys230Arg) |
single nucleotide variant |
not provided [RCV000512707] |
Chr3:49722311 [GRCh38] Chr3:49759744 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.569C>G (p.Pro190Arg) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000686689] |
Chr3:49722503 [GRCh38] Chr3:49759936 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.358A>G (p.Met120Val) |
single nucleotide variant |
Elevated serum creatine phosphokinase [RCV000678462] |
Chr3:49723016 [GRCh38] Chr3:49760449 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.629T>C (p.Met210Thr) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000687589] |
Chr3:49722443 [GRCh38] Chr3:49759876 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.215G>A (p.Gly72Glu) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000685850] |
Chr3:49723298 [GRCh38] Chr3:49760731 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.790C>T (p.Gln264Ter) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000692931] |
Chr3:49722126 [GRCh38] Chr3:49759559 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.525G>T (p.Met175Ile) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000693068]|not provided [RCV000729679] |
Chr3:49722632 [GRCh38] Chr3:49760065 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.955C>T (p.Arg319Cys) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000690678] |
Chr3:49721880 [GRCh38] Chr3:49759313 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.402+1G>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000690893] |
Chr3:49722971 [GRCh38] Chr3:49760404 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.1070G>A (p.Arg357His) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000705475] |
Chr3:49721765 [GRCh38] Chr3:49759198 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.953T>C (p.Val318Ala) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000691392] |
Chr3:49721882 [GRCh38] Chr3:49759315 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.758A>G (p.Asn253Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000705546] |
Chr3:49722241 [GRCh38] Chr3:49759674 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.792G>C (p.Gln264His) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000695460] |
Chr3:49722124 [GRCh38] Chr3:49759557 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.656T>C (p.Ile219Thr) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000698360] |
Chr3:49722343 [GRCh38] Chr3:49759776 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.62C>A (p.Thr21Asn) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000697038] |
Chr3:49723665 [GRCh38] Chr3:49761098 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.287_307del (p.Leu96_Asp102del) |
deletion |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000686546] |
Chr3:49723067..49723087 [GRCh38] Chr3:49760500..49760520 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.535A>G (p.Ser179Gly) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001065000] |
Chr3:49722622 [GRCh38] Chr3:49760055 [GRCh37] Chr3:3p21.31 |
uncertain significance |
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3 |
copy number gain |
not provided [RCV000742133] |
Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29 |
pathogenic |
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3 |
copy number gain |
not provided [RCV000742138] |
Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29 |
pathogenic |
NM_021971.4(GMPPB):c.490C>T (p.Gln164Ter) |
single nucleotide variant |
not provided [RCV000760617] |
Chr3:49722667 [GRCh38] Chr3:49760100 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.769-9C>T |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000899405] |
Chr3:49722156 [GRCh38] Chr3:49759589 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.486G>A (p.Lys162=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000981339] |
Chr3:49722671 [GRCh38] Chr3:49760104 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.641-19_641-9del |
deletion |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001061705] |
Chr3:49722367..49722377 [GRCh38] Chr3:49759800..49759810 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1016A>G (p.Asn339Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001036803] |
Chr3:49721819 [GRCh38] Chr3:49759252 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.433G>A (p.Gly145Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001060368] |
Chr3:49722724 [GRCh38] Chr3:49760157 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.759C>T (p.Asn253=) |
single nucleotide variant |
not provided [RCV000898061] |
Chr3:49722240 [GRCh38] Chr3:49759673 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.531C>A (p.Ile177=) |
single nucleotide variant |
not provided [RCV000873084] |
Chr3:49722626 [GRCh38] Chr3:49760059 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.918C>T (p.Cys306=) |
single nucleotide variant |
not provided [RCV000919558] |
Chr3:49721998 [GRCh38] Chr3:49759431 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.129+7C>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000893922] |
Chr3:49723591 [GRCh38] Chr3:49761024 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.939C>T (p.Arg313=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000887747] |
Chr3:49721977 [GRCh38] Chr3:49759410 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.951+9G>T |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000937474] |
Chr3:49721956 [GRCh38] Chr3:49759389 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_022064.5(RNF123):c.3596G>C (p.Gly1199Ala) |
single nucleotide variant |
not provided [RCV000884425] |
Chr3:49720606 [GRCh38] Chr3:49758039 [GRCh37] Chr3:3p21.31 |
benign |
GRCh37/hg19 3p21.31-21.1(chr3:45153770-53878616) |
copy number gain |
not provided [RCV000767704] |
Chr3:45153770..53878616 [GRCh37] Chr3:3p21.31-21.1 |
pathogenic |
NM_021971.4(GMPPB):c.395C>G (p.Ser132Cys) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000793053] |
Chr3:49722979 [GRCh38] Chr3:49760412 [GRCh37] Chr3:3p21.31 |
likely pathogenic|uncertain significance |
NM_021971.4(GMPPB):c.812A>G (p.Asn271Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000799524] |
Chr3:49722104 [GRCh38] Chr3:49759537 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.516C>T (p.Asn172=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001079770]|not provided [RCV000839682] |
Chr3:49722641 [GRCh38] Chr3:49760074 [GRCh37] Chr3:3p21.31 |
benign|likely benign |
NM_021971.4(GMPPB):c.109C>T (p.Gln37Ter) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000801856] |
Chr3:49723618 [GRCh38] Chr3:49761051 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.271_283del (p.Ala91fs) |
deletion |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000821842] |
Chr3:49723091..49723103 [GRCh38] Chr3:49760524..49760536 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_013334.3(GMPPB):c.-446G>A |
single nucleotide variant |
not provided [RCV000827866] |
Chr3:49724172 [GRCh38] Chr3:49761605 [GRCh37] Chr3:3p21.31 |
benign |
NM_021971.4(GMPPB):c.116A>G (p.Glu39Gly) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000800593] |
Chr3:49723611 [GRCh38] Chr3:49761044 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.937C>T (p.Arg313Cys) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000796984] |
Chr3:49721979 [GRCh38] Chr3:49759412 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.160A>C (p.Ser54Arg) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000823166] |
Chr3:49723442 [GRCh38] Chr3:49760875 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.863G>C (p.Arg288Pro) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000817393] |
Chr3:49722053 [GRCh38] Chr3:49759486 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.473G>C (p.Arg158Pro) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000814700] |
Chr3:49722684 [GRCh38] Chr3:49760117 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_013334.3(GMPPB):c.-454G>A |
single nucleotide variant |
not provided [RCV000827865] |
Chr3:49724180 [GRCh38] Chr3:49761613 [GRCh37] Chr3:3p21.31 |
benign |
NM_013334.3(GMPPB):c.-412C>T |
single nucleotide variant |
not provided [RCV000827868] |
Chr3:49724138 [GRCh38] Chr3:49761571 [GRCh37] Chr3:3p21.31 |
benign |
NM_021971.4(GMPPB):c.640+19A>G |
single nucleotide variant |
not provided [RCV000828076] |
Chr3:49722413 [GRCh38] Chr3:49759846 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.94C>T (p.Pro32Ser) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000810959] |
Chr3:49723633 [GRCh38] Chr3:49761066 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.757A>G (p.Asn253Asp) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000801719] |
Chr3:49722242 [GRCh38] Chr3:49759675 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.640+1G>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000794094] |
Chr3:49722431 [GRCh38] Chr3:49759864 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.458C>T (p.Thr153Ile) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000815814]|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV000993849] |
Chr3:49722699 [GRCh38] Chr3:49760132 [GRCh37] Chr3:3p21.31 |
pathogenic|likely pathogenic|uncertain significance |
NM_021971.4(GMPPB):c.304G>C (p.Asp102His) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000797803] |
Chr3:49723070 [GRCh38] Chr3:49760503 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.621A>G (p.Leu207=) |
single nucleotide variant |
not provided [RCV000842065] |
Chr3:49722451 [GRCh38] Chr3:49759884 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.589G>T (p.Val197Phe) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001046286] |
Chr3:49722483 [GRCh38] Chr3:49759916 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.434G>C (p.Gly145Ala) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001216870] |
Chr3:49722723 [GRCh38] Chr3:49760156 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.510G>C (p.Lys170Asn) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001208227] |
Chr3:49722647 [GRCh38] Chr3:49760080 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.299C>T (p.Thr100Ile) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001224623] |
Chr3:49723075 [GRCh38] Chr3:49760508 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.215G>C (p.Gly72Ala) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001232036] |
Chr3:49723298 [GRCh38] Chr3:49760731 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.728_746delinsACAGA (p.Arg243fs) |
indel |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001241608] |
Chr3:49722253..49722271 [GRCh38] Chr3:49759686..49759704 [GRCh37] Chr3:3p21.31 |
pathogenic |
NM_021971.4(GMPPB):c.135C>T (p.Gly45=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001224538] |
Chr3:49723467 [GRCh38] Chr3:49760900 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.129+5G>A |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001246944] |
Chr3:49723593 [GRCh38] Chr3:49761026 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.684dup (p.Met229fs) |
duplication |
Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 [RCV001197852] |
Chr3:49722314..49722315 [GRCh38] Chr3:49759747..49759748 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.806G>A (p.Gly269Asp) |
single nucleotide variant |
not provided [RCV001200165] |
Chr3:49722110 [GRCh38] Chr3:49759543 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.729G>A (p.Arg243=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000875489] |
Chr3:49722270 [GRCh38] Chr3:49759703 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.211-7C>T |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV000953822] |
Chr3:49723309 [GRCh38] Chr3:49760742 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.403-8G>A |
single nucleotide variant |
not provided [RCV000946299] |
Chr3:49722762 [GRCh38] Chr3:49760195 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.478G>A (p.Val160Met) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001226181] |
Chr3:49722679 [GRCh38] Chr3:49760112 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.288_290dup (p.Leu97dup) |
duplication |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001208354] |
Chr3:49723083..49723084 [GRCh38] Chr3:49760516..49760517 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.870G>A (p.Thr290=) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001245121] |
Chr3:49722046 [GRCh38] Chr3:49759479 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.951+28_951+29insGGGGGGGGGC |
insertion |
not provided [RCV001170008] |
Chr3:49721936..49721937 [GRCh38] Chr3:49759369..49759370 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.402+8G>A |
single nucleotide variant |
not provided [RCV000935673] |
Chr3:49722964 [GRCh38] Chr3:49760397 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.966C>T (p.Asn322=) |
single nucleotide variant |
not provided [RCV000913719] |
Chr3:49721869 [GRCh38] Chr3:49759302 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.315C>T (p.Phe105=) |
single nucleotide variant |
not provided [RCV000935503] |
Chr3:49723059 [GRCh38] Chr3:49760492 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.300T>C (p.Thr100=) |
single nucleotide variant |
not provided [RCV000889278] |
Chr3:49723074 [GRCh38] Chr3:49760507 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.940G>T (p.Val314Leu) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001071870] |
Chr3:49721976 [GRCh38] Chr3:49759409 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.478G>C (p.Val160Leu) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001070364] |
Chr3:49722679 [GRCh38] Chr3:49760112 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.997A>T (p.Asn333Tyr) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001203688] |
Chr3:49721838 [GRCh38] Chr3:49759271 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.388_389delinsAG (p.Glu130Arg) |
indel |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001216408] |
Chr3:49722985..49722986 [GRCh38] Chr3:49760418..49760419 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.727C>T (p.Arg243Trp) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001036720] |
Chr3:49722272 [GRCh38] Chr3:49759705 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1040A>G (p.Lys347Arg) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001051321] |
Chr3:49721795 [GRCh38] Chr3:49759228 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.356C>A (p.Ala119Asp) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001213231] |
Chr3:49723018 [GRCh38] Chr3:49760451 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.781C>T (p.Arg261Cys) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001054940] |
Chr3:49722135 [GRCh38] Chr3:49759568 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.128C>T (p.Ala43Val) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001055548] |
Chr3:49723599 [GRCh38] Chr3:49761032 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.887G>A (p.Arg296Gln) |
single nucleotide variant |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14 [RCV001056881] |
Chr3:49722029 [GRCh38] Chr3:49759462 [GRCh37] Chr3:3p21.31 |
uncertain significance |
GRCh37/hg19 3p21.31-21.2(chr3:48807193-51363558)x1 |
copy number loss |
not provided [RCV001259686] |
Chr3:48807193..51363558 [GRCh37] Chr3:3p21.31-21.2 |
pathogenic |
NM_021971.4(GMPPB):c.432C>T (p.Tyr144=) |
single nucleotide variant |
not provided [RCV001257177] |
Chr3:49722725 [GRCh38] Chr3:49760158 [GRCh37] Chr3:3p21.31 |
likely benign |
NM_021971.4(GMPPB):c.1027G>C (p.Val343Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV001266809] |
Chr3:49721808 [GRCh38] Chr3:49759241 [GRCh37] Chr3:3p21.31 |
likely pathogenic |
NM_021971.4(GMPPB):c.966C>G (p.Asn322Lys) |
single nucleotide variant |
Inborn genetic diseases [RCV001267546] |
Chr3:49721869 [GRCh38] Chr3:49759302 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.84C>A (p.Phe28Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV001267547] |
Chr3:49723643 [GRCh38] Chr3:49761076 [GRCh37] Chr3:3p21.31 |
uncertain significance |
NM_021971.4(GMPPB):c.1004A>T (p.Glu335Val) |
single nucleotide variant |
Elevated serum creatine phosphokinase [RCV001281580] |
Chr3:49721831 [GRCh38] Chr3:49759264 [GRCh37] Chr3:3p21.31 |
uncertain significance |